Catalent | CTLT - Operating Expenses


Catalent reported $4.78B in Operating Expenses for its fiscal quarter ending in June of 2025.



Operating Expenses Change Date
Agilent USD 1.42B 57M Sep/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
Bruker USD 900.9M 124.3M Dec/2025
Centene USD 50.96B 30.01B Dec/2025
Charles River Laboratories USD 3.41B 2.51B Sep/2025
Cigna USD 41.8B 23.4B Sep/2025
Danaher USD 5.34B 45.74B Dec/2025
Dentsply International USD 1.48B 653M Sep/2025
Elevance Health USD 49.17B 5.21B Dec/2025
Eli Lilly USD 10.31B 1.09B Dec/2025
Glaxosmithkline GBP 7.77B 2.22B Sep/2025
Hologic USD 349.4M 447.1M Dec/2025
Humana USD 33.32B 1.07B Dec/2025
Illumina USD 903M 69M Dec/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
J&J USD 18.97B 2.38B Dec/2025
Laboratory Of America USD 3.17B 101.7M Sep/2025
Lonza CHF 3.09B 564M Dec/2024
McKesson USD 104.5B 2.85B Dec/2025
Merck EUR 4.11B 117M Sep/2025
Merck USD 10.16B 558M Dec/2025
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Novartis USD 9.86B 115M Sep/2025
Pfizer USD 12.91B 79.89B Dec/2025
Quest Diagnostics USD 2.42B 4.84B Dec/2025
Repligen USD 176.13M 279K Sep/2025
Revvity USD 626.22M 25.62M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Supernus Pharmaceuticals USD 252.29M 98.98M Sep/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
UnitedHealth USD 109.96B 1.11B Dec/2025
Waters USD 661.85M 1.67B Dec/2025
West Pharmaceutical Services USD 642.5M 2.41B Dec/2025